Furosemide, sold as Lasix, should be held when a patient shows signs of dangerously low blood pressure, dehydration, or electrolyte imbalances that the drug would worsen. There is no single universal cutoff printed on the label. Instead, the decision depends on a handful of measurable indicators: blood pressure, potassium and sodium levels, kidney function, weight trends, and how the patient looks and feels. Here’s how to evaluate each one.
Low Blood Pressure and Fast Heart Rate
Furosemide works by forcing the kidneys to excrete more water and salt, which directly lowers blood volume. That makes hypotension (low blood pressure) one of the most common reasons to hold a dose. Many clinical protocols use a systolic blood pressure below 90 mmHg as the threshold, though some providers set it at 100 mmHg for patients who normally run higher. If the patient’s blood pressure drops significantly when they stand up compared to when they’re sitting or lying down, that orthostatic change is itself a red flag, even if neither reading looks critically low on its own.
A resting heart rate that’s noticeably elevated can signal that the body is compensating for low fluid volume. The FDA labeling for furosemide specifically lists tachycardia alongside hypotension as a sign of fluid or electrolyte imbalance that warrants close observation. When you see a fast heart rate paired with low or dropping blood pressure, holding the dose is the safer call until the picture stabilizes.
Potassium and Sodium Levels
Furosemide pulls potassium out of the body along with water. A potassium level below about 3.5 mEq/L is considered low, and giving another dose of furosemide at that point risks dangerous heart rhythm problems. Most protocols call for correcting potassium before resuming the drug. If a patient is already on a potassium supplement and still running low, that’s a stronger signal to pause.
Sodium matters too. Serum sodium below 136 mmol/L is classified as hyponatremia, and research in BMC Pharmacology & Toxicology found that patients receiving higher furosemide doses (250 mg or more daily) were significantly more likely to develop it. Low sodium can cause confusion, nausea, headaches, and in severe cases seizures. When sodium is already trending down, adding more furosemide pushes it further in the wrong direction.
The FDA label states plainly that electrolyte abnormalities should be corrected or the drug temporarily withdrawn.
Signs of Dehydration
Lab values don’t always tell the full story. Physical signs of dehydration are an independent reason to hold a dose, even before labs come back. The key things to watch for:
- Dry mouth and mucous membranes, which indicate moderate to severe fluid loss
- Poor skin turgor, where pinched skin on the back of the hand or forearm stays tented instead of snapping back
- Delayed capillary refill, taking more than two seconds after pressing a fingernail
- Dizziness or lightheadedness when standing
- Reduced urine output, which seems counterintuitive for a diuretic but signals the kidneys are running out of fluid to work with
- New confusion, excessive drowsiness, or lethargy
Any combination of these findings in a patient on furosemide suggests the drug has done its job too well and the next dose should be held until fluid balance improves.
Kidney Function Changes
Furosemide depends on the kidneys to work, and it can also stress them. A rising creatinine level, which reflects how well the kidneys are filtering, is a reason to pause and reassess. There’s no single creatinine number that universally triggers holding the drug, but a noticeable upward trend from a patient’s baseline, especially if it jumps 25% to 50% or more, signals that the kidneys are struggling under the fluid loss.
In hospital settings, clinicians track daily urine output closely. Michigan Medicine’s inpatient diuretic guideline considers urine output below 300 mL within two hours of a dose, or below 1,200 mL within eight hours, as a sign of diuretic resistance. At that point, the drug isn’t working effectively and continuing the same approach risks kidney injury without meaningful benefit.
Weight Trends That Signal Too Much Fluid Loss
Daily weight is one of the simplest and most reliable tools for tracking fluid balance. In heart failure management, the typical target is about 1 kilogram (roughly 2.2 pounds) of weight loss per day during active treatment of fluid overload. Losing significantly more than that in a single day suggests the diuretic is pulling fluid too aggressively.
On the flip side, patients who have reached their “dry weight,” the point where excess fluid is gone and they’re at a stable, healthy baseline, no longer need the same diuretic intensity. The 2024 ACC Expert Consensus Pathway for heart failure emphasizes that once a patient approaches or achieves normal fluid volume, the priority shifts away from aggressive diuresis. Continuing full-dose furosemide past that point risks dehydration and electrolyte problems without added benefit.
Sick Days With Vomiting or Diarrhea
If you’re taking furosemide at home and develop vomiting, diarrhea, or any illness that keeps you from drinking enough fluids, the standard “sick day” guidance is to temporarily stop diuretics. This recommendation appears across more than 20 clinical guidance documents reviewed in a systematic scoping review published in Kidney Medicine. The logic is straightforward: furosemide removes fluid, and so does the illness. Together, they can quickly push you into dangerous dehydration and kidney injury.
One important caveat: if you take two or more tablets of furosemide daily, multiple guidance documents recommend contacting your healthcare provider before stopping rather than just skipping doses on your own. For people with significant heart failure, suddenly stopping the drug can lead to rapid fluid buildup, so the risks of stopping and continuing both need to be weighed. The Diabetes Canada “SADMANS” acronym, which lists diuretics alongside several other medications to pause during acute illness, is a widely referenced tool for remembering which drugs to hold on sick days.
Hearing Changes
Furosemide carries a lesser-known risk of ototoxicity, which is damage to the inner ear. The earliest warning sign is usually tinnitus, a ringing or buzzing sound that no one else can hear. This can progress to actual hearing loss, balance problems, dizziness, or difficulty walking in the dark. According to Cleveland Clinic, these symptoms can appear right away or develop gradually over months to years.
If you notice any new ringing in your ears, muffled hearing, or unexplained balance issues after starting furosemide, that warrants prompt evaluation. Stopping the drug won’t reverse damage that’s already occurred, but it can prevent further harm. This side effect is more common at higher doses and with rapid intravenous administration than with standard oral tablets, but it’s worth knowing about regardless of your dose.